Immunology and Microbiology
Inflammatory Bowel Disease
100%
Gut Microbiome
75%
Microbiome
49%
Transplant Procedure
33%
Crohn's Disease
31%
Metagenomics
23%
Metabolome
21%
Intestine Flora
19%
Gene Expression
18%
Microflora
17%
Enteritis
16%
Single Nucleotide Polymorphism
13%
Population
12%
Whole Exome Sequencing
12%
C-Reactive Protein
11%
Metabolite
11%
Metabolism
10%
Expression Analysis
10%
Lung Transplantation
10%
DNA Extraction
10%
TFRC
10%
Coronary Artery
10%
Primary Sclerosing Cholangitis
10%
Solid Organ Transplantation
10%
Hypoxia Inducible Factor 1
10%
Genetic Variation
10%
Liver Transplantation
10%
Acute Graft Rejection
10%
Human Leukocyte Antigen
10%
Mental Health
9%
Eotaxin
8%
Interleukin-6
8%
Serum Amyloid A
8%
Small Intestine
7%
Microbial Diversity
7%
Fatty Acid Metabolism
7%
Virulence Factor
6%
Ulcerative Colitis
6%
Tumor Necrosis Factor
6%
Expression Quantitative Trait Loci
6%
Antimicrobial Resistance
5%
Mucosa
5%
Taxon
5%
Keyphrases
Inflammatory Bowel Disease
76%
Gut Microbiome
42%
Kidney Transplant Recipients
22%
Health-related Quality of Life
21%
Clinical Phenotype
21%
Host-microbe Interactions
21%
Crohn's Disease
20%
Fibrostenotic
18%
Primary Sclerosing Cholangitis
15%
Transcriptional Network
12%
Inflammatory Biomarkers
11%
Redox Status
11%
Microbiota
11%
Microbiome
11%
Oxidation-reduction Potential
10%
Iron Deficiency
10%
Potential Measure
10%
Modifying Variants
10%
Hypoxia-inducible factor-1α (HIF-1α)
10%
Genetic Risk Score
10%
Intestinal Inflammation
10%
Lung Transplantation
10%
Endoscopic Disease Activity
10%
Disease Phenotype
10%
Riboflavin
10%
Early Onset
10%
Exome Sequencing
10%
Genetic Etiology
10%
End-stage Lung Disease
10%
Predictive Value
10%
Biological Therapy
10%
Gut Metabolome
10%
Acute Cellular Rejection
10%
Human Leukocyte Antigen
10%
Donor-recipient Matching
10%
Genome-wide Meta-analysis
10%
Phenotypic Mismatch
10%
Post-liver Transplantation
10%
Microbial Composition
8%
Mucosa-associated Microbiota
8%
TNF-α Antagonists
8%
Healthy Controls
8%
Gut Health
7%
Fecal Calprotectin
7%
Gene Expression
7%
Disease Activity
7%
Fibrostenosis
6%
Metagenomic Next-generation Sequencing (mNGS)
6%
Transcriptomics
6%
Bifidobacterium
6%
Medicine and Dentistry
Inflammatory Bowel Disease
55%
Gut Microbiome
32%
Kidney Graft
22%
Quality of Life
21%
Biological Marker
21%
Disease Activity
21%
Enteritis
11%
Thrombosis
10%
Pirfenidone
10%
Cell Proliferation
10%
Fibroblast
10%
Hypoxia Inducible Factor 1
10%
Lung Transplantation
10%
Silo-Filler's Disease
10%
Iron Deficiency
10%
Liver Transplantation
10%
Genome Wide Association Study
10%
Genetic Variability
10%
Genetic Risk
10%
Population
8%
Gut
8%
C Reactive Protein
8%
Disease
7%
Small Intestine
7%
Crohn's Disease
7%
Eotaxin
7%
Serum Amyloid A
7%
Interleukin-6
7%
Microbiome
6%
Ulcerative Colitis
6%
